PATHOQ
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PATHOQ Trademark

Serial Number: 79413517 • Registration: 8026609

PATHOQ is a trademark filed by Wuhan ABclonal Biotechnology Co., Ltd. on September 30, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Wuhan ABclonal Biotechnology Co., Ltd. (5 trademarks)

Room 01, Floor 4, Building 7,

Entity Type: 99

Trademark Details

Filing Date

September 30, 2024

Registration Date

November 18, 2025

Published for Opposition

September 30, 2025

Goods & Services

Enzyme preparations for industrial purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes, namely, biological preparations for use in industry and science, biological preparation for use in cell cultures other than for medical or veterinary use; bacteriological preparations, namely, bacteriological culture mediums other than for medical and veterinary use; biological tissue cultures, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; biochemical catalysts; reagent paper, other than for medical or veterinary purposes

Reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; bacterial preparations for medical and veterinary use; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, biological preparations for use in cell cultures for medical purposes, biological preparations for the treatment of immune system related diseases and disorders; chemical preparations for medical purposes, namely, chemical preparations for the treatment of cancer; chemical preparations for medical purposes, namely, chemical preparations for sanitary use; chemical preparations for medical purposes, namely, chemical preparations for the diagnosis of tumors, reproductive and immune system related diseases and disorders; enzyme preparations for medical purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes

Research and development of new products for others; technological research in the field of DNA sequencing; technological research in the field of cell engineering technology; scientific and technological services, namely, technological research on tumors and tumor microenvironment, immunology, signaling pathways, molecular biology, and cell biology in the life science research field; chemical analysis; chemistry services, namely, research and development in the field of chemistry; chemical research; bacteriological research; biological research; conducting clinical trials for others; medical research; Medical research laboratories

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Jun 6, 2026 FICS
FINAL DISPOSITION PROCESSED
Jun 5, 2026 FIMP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2026 REAP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 18, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
REFUSAL PROCESSED BY IB
Aug 29, 2025 RFNP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2025 CNSA
ATTORNEY REVIEW COMPLETED
Aug 29, 2025 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Aug 29, 2025 CREV
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2025 TROA
NON-FINAL ACTION WRITTEN
Jul 31, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2025 TROA
ASSIGNED TO EXAMINER
Jun 23, 2025 DOCK
REFUSAL PROCESSED BY IB
May 31, 2025 RFNT
CORRECTION TRANSACTION RECEIVED FROM IB
May 23, 2025 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 7, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 7, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 19, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 13, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2025 REPR